Combination therapy: Future directions of immunotherapy in small cell lung cancer-Reference-Cited by-同舟云学术

Combination therapy: Future directions of immunotherapy in small cell lung cancer

Published:2021-01 Issue:1 Volume:14 Page:100889
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Huang Wei,Chen Jia-Jia,Xing Rui,Zeng Yue-Can

Funder

Foundation of Educational Commission of Liaoning Province of China

Key Projects of Department of Science and Technology of Liaoning Province

Doctoral Start-up Foundation of Liaoning Province

Excellent Young Teachers Program of China Medical University

China Medical University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference111 articles.

1. Salem A, Mistry H, Hatton M, Locke I, Monnet I, Blackhall F and Faivre-Finn C (2018). Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol e185335.

2. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?;Blackhall;Lancet Oncol,2018

3. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer;Hanna;J. Clin. Oncol.,2006

4. Treatment options for small cell lung cancer - do we have more choice?;Puglisi;Br. J. Cancer,2010

5. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data;Rossi;J. Clin. Oncol.,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for small cell lung cancer: the current state and future trajectories;Discover Oncology;2024-08-16

2. Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer;Journal of Hematology & Oncology;2024-07-27

3. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?;Pharmaceuticals;2024-07-26

4. Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report;Frontiers in Oncology;2024-06-14

5. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management;Cellular Signalling;2024-01